Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DEFB103A - Early Parkinson's disease: peripheral blood
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DEFB103A - Psoriasis response to brodalumab: dose response and time course
DEFB103A - Psoriasis lesional and non-lesional skin
DEFB103A - U2OS osteosarcoma cell line response to strigolactone analogs ST362 and MEB55: 24 hours
DEFB103A - Head and neck squamous cell carcinoma tumors harboring human papillomavirus
DEFB103A - Rho kinase inhibition effect on epidermal keratinocyte in vitro
DEFB103A - Electric pulse stimulation in vitro exercise model: primary myotubes
DEFB103A - Psoriasis vulgaris ACCEPT cohort: paired lesional and non-lesional skin
DEFB103A - NOTCH antagonist SAHM1 effect on T-ALL cell lines
DEFB103A - Epithelial stem cells derived from induced pluripotent stem cells
DEFB103A - miR-542-3p overexpression effect on TP53 wild-type osteosarcoma cell line
DEFB103A - U2OS osteosarcoma cell line response to strigolactone analogs ST362 and MEB55: 6 hours
DEFB103A - H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response
DEFB103A - H3K79 histone methyl transferase DOT1L inhibitor Compound 55 effect on breast cancer cells: dose response
DEFB103A - PGC-1-related coactivator depletion
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on